Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to B-cell Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Treatment of Hematological Malignancy With Novel CAR-T Cells.
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Study of Out of Specification for Tisagenlecleucel
- Status
- RECRUITING
- Phase
- PHASE3
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
- Status
- UNKNOWN
- Phase
- PHASE1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- RECRUITING
- Phase
- PHASE1
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- Status
- RECRUITING
- Phase
- PHASE1
CD19-CAR-T Cells in Patients With R/R B-ALL
- Status
- UNKNOWN
- Phase
- PHASE1
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2